These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15077037)

  • 41. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group.
    Kahan BD; Rajagopalan PR; Hall M
    Transplantation; 1999 Jan; 67(2):276-84. PubMed ID: 10075594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy.
    Aoyagi T; Yamashita K; Suzuki T; Uno M; Goto R; Taniguchi M; Shimamura T; Takahashi N; Miura T; Okimura K; Itoh T; Shimizu A; Furukawa H; Todo S
    Am J Transplant; 2009 Aug; 9(8):1732-41. PubMed ID: 19519810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. II. Effects of adjuvant immunosuppressive drugs.
    Thomas JM; Carver M; Cunningham P; Sash C; Park K; Thomas F
    Transplantation; 1989 Feb; 47(2):209-15. PubMed ID: 2645699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complete withdrawal of immunosuppression in kidney allograft recipients: a prospective study in rhesus monkeys.
    Jonker M; van den Hout Y; Neuhaus P; Ringers J; Kuhn EM; Bruijn JA; Schuurman HJ; Noort R; Bontrop RE; Claas FH; van Rood JJ
    Transplant Proc; 1998 Aug; 30(5):2451-3. PubMed ID: 9723534
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
    Kenyon NS; Fernandez LA; Lehmann R; Masetti M; Ranuncoli A; Chatzipetrou M; Iaria G; Han D; Wagner JL; Ruiz P; Berho M; Inverardi L; Alejandro R; Mintz DH; Kirk AD; Harlan DM; Burkly LC; Ricordi C
    Diabetes; 1999 Jul; 48(7):1473-81. PubMed ID: 10389857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys.
    Yang H; Chen G; Kanai N; Shum J; Garcia B; Huang X; Min W; Luo Y; Dutartre P; Zhong R
    Transplantation; 2003 Apr; 75(8):1166-71. PubMed ID: 12717197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation.
    van Rijen MM; Kuijf ML; Metselaar HJ; Tilanus HW; Bouma GJ; de Weger RA; Jonker M; Kwekkeboom J
    Transplantation; 2002 May; 73(10):1666-72. PubMed ID: 12042657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD154 blockade, sirolimus, and donor-specific transfusion prevents renal allograft rejection in cynomolgus monkeys despite homeostatic T-cell activation.
    Pearl JP; Xu H; Leopardi F; Preston E; Kirk AD
    Transplantation; 2007 May; 83(9):1219-25. PubMed ID: 17496539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Control of intestinal allograft rejection by FTY720 and costimulation blockade.
    Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW
    Transplant Proc; 2005; 37(1):114-5. PubMed ID: 15808565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.
    Sho M; Sandner SE; Najafian N; Salama AD; Dong V; Yamada A; Kishimoto K; Harada H; Schmitt I; Sayegh MH
    Ann Surg; 2002 Nov; 236(5):667-75. PubMed ID: 12409674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
    Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
    Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In utero hematopoietic stem cell transplants prolong survival of postnatal kidney transplantation in monkeys.
    Mychaliska GB; Rice HE; Tarantal AF; Stock PG; Capper J; Garovoy MR; Olson JL; Cowan MJ; Harrison MR
    J Pediatr Surg; 1997 Jul; 32(7):976-81. PubMed ID: 9247216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppression.
    Sánchez-Fueyo A; Domenig C; Strom TB; Zheng XX
    Transplantation; 2002 Sep; 74(6):898-900. PubMed ID: 12364878
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
    Badell IR; Thompson PW; Turner AP; Russell MC; Avila JG; Cano JA; Robertson JM; Leopardi FV; Strobert EA; Iwakoshi NN; Reimann KA; Ford ML; Kirk AD; Larsen CP
    Am J Transplant; 2012 Jan; 12(1):126-35. PubMed ID: 21920020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-transplant antibody screening and anti-CD154 costimulation blockade promote long-term xenograft survival in a pig-to-primate kidney transplant model.
    Higginbotham L; Mathews D; Breeden CA; Song M; Farris AB; Larsen CP; Ford ML; Lutz AJ; Tector M; Newell KA; Tector AJ; Adams AB
    Xenotransplantation; 2015; 22(3):221-30. PubMed ID: 25847130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
    Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C
    Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kidney transplantation in rhesus monkeys. Matching for D/DR antigens, pretransplant blood transfusions, and immunological monitoring before transplantation.
    Borleffs JC; Marquet RL; de By-Aghai Z; van Vreeswijk W; Neuhaus P; Balner H
    Transplantation; 1982 Mar; 33(3):285-90. PubMed ID: 6461114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interleukin-15 receptor blockade in non-human primate kidney transplantation.
    Haustein S; Kwun J; Fechner J; Kayaoglu A; Faure JP; Roenneburg D; Torrealba J; Knechtle SJ
    Transplantation; 2010 Apr; 89(8):937-44. PubMed ID: 20134394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.